Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05314686
Other study ID # TelerehApp-Valid/Feasib
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2022
Est. completion date March 31, 2024

Study information

Verified date February 2023
Source ADIR Association
Contact Tristan Bonnevie, PhD
Phone 0235592970
Email t.bonnevie@adir-hautenormandie.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective study will be held in two steps. The aim of the first step is to assess the technical validity of transmitting data remotely from different devices connected to a telerehabilitation system. These will include real-time oximetry data during exercise on a cycle ergometer (heart rate and transcutaneous oxygen saturation) as well as daily step count from a commercially available physical activity tracker. The aim of the second step of the study is to assess the clinical feasibility of using the telerehabilitation system in real life conditions (in the home environment). Briefly, participants will benefit from a eight weeks pulmonary rehabilitation program performed at home, using the telerehabilitation system. Further details about the content of the program and the outcomes are provided below.


Description:

Before taking part in the study, participants will undergo an incremental cardiopulmonary exercise testing as their baseline assessment before referral to a pulmonary rehabilitation program. Participants referred for pulmonary rehabilitation to the ADIR Association will be screened for eligibility. They will be contacted to initiate their program. During the first session, they will be offered to participate in the study. This protocol will be held in two steps : the first step will aim to assess the clinical validity of the data transmitted remotely through the system (from two different devices) and the second step will aim to assess the clinical feasibility of using the system in the home environment. Participant recruitment for each of these steps will be performed chronologically (the first twenty eligible participants will participate in the technical validity step of the study and the last twenty eligible participants will participate in the clinical feasibility step). Step one: Clinical validity. The first step of the study aims to assess the clinical validity of data transmitted remotely from two devices connected to the telerehabilitation system (a. oximetry data during exercise and b. daily step count from a commercially available physical activity tracker). 1. Oxymetry data during exercise on a cycle ergometer. Participants who agree to participate will be trained to use the system within the pulmonary rehabilitation centre. Training includes different steps such as to turn on the tablet, to connect to the application, to start the session using the app, to synchronise the oximeter with the app, to perform the session and to validate the end of the session. Participants will be asked to perform five endurance exercise sessions of forty-five minutes each, over five different days, within the centre. During these sessions a connected pulsed oximeter device will record heart rate and transcutaneous oxygen saturation at a frequency of one hertz. These data will be recorded in the internal memory of the oximeter itself as well as transmitted in real-time through Bluetooth to the app. The app will transmit the data to a secured remote server through the Global System for Mobile communication network. These two datasets (those locally stored and those remotely transmitted) will be analysed and compared (proportion of artefact, data deletion, data transformation, comparability etc - see outcomes for further details). 2. Data from a physical activity tracker. Concurrently, the same participants will be asked to wear a physical activity tracker over a ten-day period. The data (daily step count) will be automatically and daily transmitted to the app through Bluetooth and then from the app to the remote secured server. Participants will be asked to remove the sensor when going to bed and to note the number of steps displayed on the screen on a standardized data sheet. Step two: Clinical feasibility. The aim of the second step of the study is to assess the clinical feasibility of using the telerehabilitation system in real life conditions (in the home environment), during an eight week period. During their initial pulmonary rehabilitation session (held in the centre), participants will be offered to perform their pulmonary rehabilitation program at home, using the telerehabilitation system. Those who agree to participate will be taught to use the system during this first face-to-face session. The telerehabilitation system as well as a cycle ergometer will be subsequently provided in their home environment by a local home healthcare provider. The telerehabilitation program will take place over an eight-week period and includes: - Endurance exercise training on a cycle ergometer (performed independently with remote monitoring or through video conference (also with remote monitoring), according to the participant's preference), three times per weeks. The duration of the sessions along with the training intensity will be progressively adjusted using an automated algorithm (aimed to first increase the training duration up to forty-five minutes and then workload intensity). The algorithm is based on previous sessions performed, monitored data and perceived exertion. - Peripheral muscle strengthening using the app (the patient will be requested to reproduce different exercises after watching a video) or through video conference, three times per weeks (thirty minutes). - Daily walking (automated coaching based on Demeyer et al. Thorax. 2017). - Self management education (one to nine sessions according to each individual's needs, scheduled through videoconference). - A self evaluation of symptoms through daily or weekly questionnaires. Different types of alerts will be triggered at the center according to remote monitoring : "non-adherence", "clinical issue" during endurance exercise sessions and change in "symptoms". Participants will be encouraged to contact physiotherapists at the centre for any situation that would require assistance (related to their program or to cope with any technical issue).


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date March 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age superior to eighteen years. - Stable (> four weeks) chronic obstructive pulmonary disease, GOLD stage II to IV - Referred to pulmonary rehabilitation (no contraindication to exercise training on a cycle ergometer). - With or without oxygen during exercise. Specific inclusion criteria for the first step of the study: - Able to perform forty-five minutes of exercise training on a cycle ergometer. Specific inclusion criteria for the second phase of the study: - Person of legal age who may be present during home exercise sessions (relatives). Non-inclusion Criteria: - Pregnancy or likely to be. - Guardianship. - Unable to consent. - Referred to pulmonary rehabilitation before lung cancer surgery. - Referred to pulmonary rehabilitation before lung volume reduction surgery scheduled in the next few months. Exclusion Criteria: - Consent withdrawal

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Five exercise sessions of forty-five minutes within the pulmonary rehabilitation centre and ten days of using a physical activity tracker.
Five exercise sessions of forty-five minutes within the centre on a cycle ergometer using a pulse oximetry device connected to the telerehabilitation system through Bluetooth. Data recorded in the internal memory of the pulse oximeter will be compared with those transmitted through the telerehabilitation system. Ten days of use of a physical activity tracker connected to the telerehabilitation system. Self-reported daily step count by the participants (using a standardized data sheet) will be compared with the daily step count transmitted through the telerehabilitation system.
Telerehabilitation
An eight-week program including: Endurance training on a cycle ergometer (performed independently with remote monitoring or through video conference, according to the participant's preference), three times per week. Training prescription is progressively adjusted using an automated algorithm (aimed to first increase the training duration and then workload intensity). Peripheral muscle strengthening using the app (the patient will be requested to reproduce different exercises after watching a video) or through video conference, three times per week (thirty minutes). Daily walking with automated coaching. Self management education (one to nine sessions according to each individual needs, scheduled through videoconference). A self evaluation of symptoms through daily or weekly questionnaires. Different types of alert will be triggered at the center according to remote monitoring: "non-adherence", "clinical issue" during endurance exercise sessions and change in "symptoms".

Locations

Country Name City State
France ADIR Association Bois-Guillaume ADIR Association

Sponsors (5)

Lead Sponsor Collaborator
ADIR Association CogSci, Groupe Havrais d'Aide aux Handicapés Respiratoires, KerNel Biomedical, Union des Kinésithérapeutes Respiratoires

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Technical validity of the data transmitted remotely - pulse oximeter - concordance between datasets. Comparison of paired datasets between the data recorded locally within the internal memory of the pulse oximeter and those collected from the telerehabilitation system. Data will be recorded immediately after the intervention.
Primary Technical validity of the data transmitted remotely - physical activity tracker - concordance between datasets. Comparison of paired dataset between the daily data, either automatically collected from the telerehabilitation system or self-reported by the participant (visually displayed on the physical activity tracker). Data will be recorded immediately after the intervention.
Primary Technical validity of the data transmitted remotely - pulse oximeter - proportion of sessions transmitted. The number of exercise sessions retrieved from the telerehabilitation system will be expressed in relation to the number of sessions performed. Data will be recorded immediately after the intervention.
Primary Technical validity of the data transmitted remotely - physical activity tracker - proportion of sessions transmitted. The number of days with physical activity data retrieved from the telerehabilitation system will be expressed in relation to the number of days that the tracker has been worn by the participant. Data will be recorded immediately after the intervention.
Primary Technical validity of the data transmitted remotely - pulse oximeter - proportion of common usable data. The proportion of data without artefacts will be compared between datasets. Artefacts will be identified for heart rate when values indicate two hundred fifty beats per minute and for transcutaneous oxygen saturation when values indicate hundred percent. Data will be recorded immediately after the intervention.
Primary Technical validity of the data transmitted remotely - pulse oximeter - number of session required to be autonomous when using the system. Participants will be taught to use the system and they will be requested to set data collection autonomously during the four next sessions. They will be considered autonomous when they will be able to set data collection autonomously without error. The number of sessions (after the first session) required to reach autonomy will be collected. Data will be recorded immediately after the intervention.
Secondary Endurance exercise capacity - constant workload exercise testing. Time to exhaustion (in second) during a constant workload exercise testing on a cycle ergometer at seventy-five percent of the maximal workload achieved during a previously performed incremental cardiopulmonary exercise testing. Baseline and immediately after the intervention.
Secondary Endurance exercise capacity - six-minute walking test. Number of meters performed during the six-minutes walking test, performed in a thirty metre long corridor. Baseline and immediately after the intervention.
Secondary Endurance exercise capacity - six-minute stepper test. Number of steps performed during the six-minutes stepper test. Baseline and immediately after the intervention.
Secondary Maximal voluntary isometric quadriceps force. Data will be recorded using a handheld manometer. Baseline and immediately after the intervention.
Secondary Self-reported quality of life. Saint George's Respiratory Questionnaire. Baseline and immediately after the intervention.
Secondary Functional dyspnea. Modified Medical Research Council dyspnea scale. Baseline and immediately after the intervention.
Secondary Health status. Chronic obstructive pulmonary disease Assessment Test. Baseline and immediately after the intervention.
Secondary Anxiety. Hospital And Anxiety questionnaire - anxiety sub scale. Baseline and immediately after the intervention.
Secondary Depression. Hospital And Anxiety questionnaire - depression sub scale. Baseline and immediately after the intervention.
Secondary Cognitive Function. Montreal Cognitive Assessment test. Baseline and immediately after the intervention.
Secondary Objective physical activity. Objective physical activity will be assessed using a physical activity tracker (different from the one used with the telerehabilitation system) and expressed as daily step count over a ten-day period. A given day will be considered as valid if the device is worn at least eight hours and the outcome will be considered as valid for a given participant if the measurement includes at least four valid week days. Baseline and immediately after the intervention.
Secondary Adherence - exercise training. Adherence will be assessed as the number of exercise training sessions performed in relation to the number of sessions prescribed. Data will be collected through study completion, an average of 8 weeks.
Secondary Adherence - self-management education. Adherence will be assessed as the number of self-management education sessions performed in relation to the number of sessions prescribed. Data will be collected through study completion, an average of 8 weeks.
Secondary Adherence - symptoms monitoring questionnaires. Adherence will be assessed as the number of days with fulfilled questionnaires relative to the number of days. Data will be collected through study completion, an average of 8 weeks.
Secondary Use of the telerehabilitation system. Logs related to the different components of the programs will be retrieved from the telerehabilitation system (number of click to each component of the eight-week period). Data will be collected through study completion, an average of 8 weeks.
Secondary Usability of the system. Usability of the system will be assessed using the System Usability Scale. Data will be collected immediately after the intervention.
Secondary Satisfaction - standardized questionnaire. Satisfaction will be assessed using the Client Satisfaction Questionnaire-8. Data will be collected immediately after the intervention.
Secondary Satisfaction - purpose designed survey. Satisfaction will be assessed using purpose designed surveys intended for participants, their relatives and healthcare professional in charge of telerehabilitation program (Lickert scale). Data will be collected immediately after the intervention.
Secondary Emotional perception of the system. Emotional perception of the system will be assessed using Emocards. Data will be collected immediately after the intervention.
Secondary Participant's flow. Participant's flow with the system will be assessed using the FKS scale from Rheinberg et al. (2003). Data will be collected immediately after the intervention.
Secondary Motivation to participate in the program using the telerehabilitation system. Motivation will be assessed through a one hour semi-directed interview. Data will be collected immediately after the intervention.
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy